Vitamin D and anemia in chronic kidney disease

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

Abstract

A considerable proportion of patients with chronic kidney disease develop anemia. Several factors are known to contribute to this renal anemia, like EPO deficiency, EPO hyporesponsiveness and functional iron deficiency due to increasing concentrations of hepcidin. Recent studies showing an association in abnormalities of the vitamin D system with low hemoglobin (Hb) levels and erythropoietin stimulating agent (ESA) resistance suggest cross-talk between the vitamin D system and erythropoiesis. The administration of either inactive or active vitamin D has been associated with an improvement of anemia and reduction in EPO hyporesponsiveness. Potential links between the vitamin D system and erythropoiesis are described in this chapter.
Original languageEnglish
Title of host publicationVitamin D in Chronic Kidney Disease
PublisherSpringer International Publishing
Pages391-404
ISBN (Electronic)9783319325071
ISBN (Print)9783319325057
DOIs
Publication statusPublished - 2016

Publication series

NameVitamin D in Chronic Kidney Disease

Cite this

van Breda, F., & Vervloet, M. G. (2016). Vitamin D and anemia in chronic kidney disease. In Vitamin D in Chronic Kidney Disease (pp. 391-404). (Vitamin D in Chronic Kidney Disease). Springer International Publishing. https://doi.org/10.1007/978-3-319-32507-1_23